Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05670236 · ClinicalTrials.gov registry record · Phase 4
Effect of Knee Pain on Walking Biomechanics
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
NCT05670236: Completed Phase 4 study, sponsored by The Cleveland Clinic.
NCT05670236 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 55 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05670236, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
Study Summary
The goal of this study is to determine if pain in one knee influences loading of the other knee during different types of walking. The main questions it aims to answer are: * How does unilateral knee pain affect contralateral knee joint loading during different types of walking? * Does movement and loading change at the hips, knees, and ankles during prolonged walking in persons with painful knee osteoarthritis? Participants will: * Fill out questionnaires/surveys * Complete clinical examinations * Walking on a treadmill under different types of walking conditions * Receive two knee injections For comparison purposes, researchers will also enroll healthy participants.
Primary Outcome
Contact forces estimated with musculoskeletal modeling
Interventions
- DRUG Lidocaine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2024-07-19 |
| Phase | Phase 4 |
What the finished NCT05670236 record still lists
NCT05670236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Lidocaine Hydrochloride is the first listed.
NCT05670236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05670236 about?
NCT05670236 is a clinical study titled "Effect of Knee Pain on Walking Biomechanics". The goal of this study is to determine if pain in one knee influences loading of the other knee during different types of walking. The main questions it aims to answer are: * How does unilateral knee pain affect contralateral knee joint loading during different types of walking? * Does movement and...
What is the current status of trial NCT05670236?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2023-01-25. Estimated completion is 2024-07-19.
What interventions are being tested in trial NCT05670236?
The interventions under investigation include: Lidocaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT05670236?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05670236's enrollment target sits among peer trials
55 1218th of 2000 higher than 778 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI